The page is the record's research on the issuer — no analyst, no rating, no view. # Estrella Immunopharma, Inc. (NASDAQ: ESLAW) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Estrella Immunopharma, Inc., listed on NASDAQ under ticker ESLAW, with ISIN US2975841121. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US). The security type is Corporate, and the sector is 2836 Biological Products, (No Diagnostic Substances). The segment and jurisdiction are not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 29 filings in the twelve months to 2026-11-08, across 26 filing days. The median gap between filing days is 7 days. The latest filing is dated 2026-11-04 and is of type directors_dealings, 4 days before the record date. The NASDAQ peer median is 6.0 days for cadence, 52 filings and 5.0 days for latency across 4359 issuers. The sector peer median is 5.5 days for cadence, 65.5 filings and 4.0 days for latency across 176 issuers. The issuer's filings are below the NASDAQ median and below the sector median on filings, and its cadence gap is above the NASDAQ median and the sector median. ## Auditor The auditor of record is Macias Gini & O'Connell LLP, located in Irvine, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. The market's vintage is sealed. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001844417.json (identity.name) - https://mcp.us-cm-kg.ai/events/NASDAQ/ESLAW (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1844417/000121390026029357/ea0276230-10k_estrella.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ESLAW (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ESLAW · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp